Curaleaf Holdings, Inc. CURLF, a leading international cannabis company, reported its financial results for the first quarter of 2024. Curaleaf’s CEO, Matt Darin, highlighted the company's focus on expanding its brand globally, leveraging significant market catalysts such as legislative changes in key regions like New York, Germany and several U.S. states.
Financial Performance
Curaleaf announced a first-quarter revenue of $339 million, reflecting a 2% increase year-over-year.
The adjusted gross margin rose to 48%, showcasing efficient cost management and operational improvements.
The company's Adjusted EBITDA stood at $77 million, representing 23% of the revenue. This figure indicates a 40 basis point enhancement compared to the same period last year, illustrating subtle yet positive financial shifts.
Despite these gains, Curaleaf reported a significant net loss of $48.3 million, signaling ongoing investments and expansion costs that impact short-term profitability.
Strategic Developments
The quarter saw the launch of innovative products such as Stir by Zero Proof, a fast-acting THC beverage in Illinois and Stiq, a new vape product in Arizona. An there was the acquisition of Northern Green Canada (NGC).
The company ended the quarter with $105 million in cash as well as generating $46 million in operating cash flow and $33 million in free cash flow.
Global Expansion And Market Dynamics
With the cannabis industry's landscape evolving, Curaleaf's transition from a multi-state operator (MSO) to a multi-country pperator (MCO) is timely. The company now operates in over 15 countries, with recent regulatory advancements likely to bolster its market position.
Scanning through cannabis spreadsheets can take some time. To learn more about investing, don't miss the opportunity to join us at the 19th Benzinga Cannabis Capital Conference in Chicago this October 8-9. Engage with top executives, investors, policymakers, and advocates to explore the industry's future. Secure your tickets now before prices increase by following this link.
Photo: AI-Generated Image.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.